Page last updated: 2024-09-03

omega-n-methylarginine and Diabetic Foot

omega-n-methylarginine has been researched along with Diabetic Foot in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, J; Liu, H; Liu, X; Ming, J; Xing, Y; Zhang, N; Zhang, X1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Diabetic Foot

ArticleYear
Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS.
    Journal of molecular endocrinology, 2017, Volume: 58, Issue:4

    Topics: Adenoviridae; Case-Control Studies; Caspase 3; Cell Survival; Cells, Cultured; Chromones; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Gene Expression Regulation; Genetic Vectors; Glucose; Human Umbilical Vein Endothelial Cells; Humans; L-Lactate Dehydrogenase; Male; Malondialdehyde; Middle Aged; Morpholines; Neovascularization, Physiologic; Netrin-1; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction

2017